Login to Your Account



First AIDS prevention trial testing integrase inhibitor in China

By John Fox
Staff Writer

Wednesday, April 9, 2014

HONG KONG — A potent investigational new AIDS drug that has shown promising results as pre-exposure prophylaxis against HIV in macaque monkeys, is now being considered for testing in a clinical trial among high-risk individuals in Hong Kong and elsewhere in China.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription